Wolfson Group, a Scotland-based international consumer wellness company, is expanding U.S. distribution of its non-prescription weight management brand PhenQ as new data shows rapid growth in the use of prescription GLP-1 medications. A June 2026 report from PwC found that 21% of U.S. households included a current GLP-1 user as of May 2026, up from 9% in January 2025. The surge underscores a shifting weight management landscape in which prescription drugs are gaining visibility, but consumers continue to navigate a diverse marketplace of nutritional products, fitness programs, and lifestyle approaches.
Wolfson Group participates in the non-prescription category through PhenQ, which is available to U.S. consumers through Amazon and, more recently, OneLavi.com. The company said the additional retail channel reflects a broader U.S. strategy of developing multiple distribution points while supporting its portfolio of established wellness brands.
“The weight management market is evolving, and consumers have more choices than ever before,” said the founder and CEO of Wolfson Group. “Prescription medications have become an important part of the conversation, but nutrition, physical activity and everyday lifestyle habits remain central to how people think about managing their weight. Our focus is on serving consumers in the non-prescription wellness market.”
The company emphasized that PhenQ is a non-prescription product and should not be viewed as a substitute for prescribed medical treatments. Wolfson Group believes the growing visibility of GLP-1 medications creates opportunities for greater consumer education about the different categories of products and services available, their intended purposes, and the importance of making informed decisions.
Wolfson Group’s portfolio extends beyond weight management to cognitive wellness, gut health, and men’s wellbeing, with brands including PhenQ, TestoPrime, NooCube, and YourBiology. The company said it will continue investing in consumer education, science-led brand development, and expanded U.S. distribution following its participation in the September ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida.
